The FDA is now expected to consider the committee’s views and then decide whether to approve the drug or pump the brakes. That decision doesn’t happen for a while – probably not until next year. Approval will be a key target; It will be the first approval of a new …
Read More »The FDA advisory panel is not sure about the effectiveness of the new Alzheimer’s disease drug
